ObsEva, Korro bring in new CEOs; plus Cerebral, Spartan, Apnimed and Micronoma

Women’s reproductive health company  ObsEva S.A. (SIX:OBSN; NASDAQ:OBSV) hired Brian O’Callaghan as CEO , effective Dec. 1. He succeeds Ernest Loumaye, who will continue to serve as a board member. O’Callaghan was CEO of Petra Pharma Corp.

Ram Aiyar joined RNA base editing company  Korro Bio Inc. as CEO and a board member. He co-founded and was CFO and CBO at  Corvidia Therapeutics Inc...